| Edit |   |
|---|
| Product Name | L-371,257 |
|---|
| Description | Potent, high affinity human oxytocin (OT) receptor antagonist (Ki = 4.6 nM) that displays > 800-fold selectivity over human arginine vasopressin receptors V1a and V2. Antagonizes oxytocin-induced contractions in isolated rat uterine tissue (pA2 = 8.44) and in anesthetised rats following intravenous and intraduodenal administration. Decreases length of U-87MG cell projections induced by retinoic acid (Cat.No.0695). Orally active. Purity 99%. MW (observed): 507.59 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1-[4-[(1-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]-4-(2-oxo-2H-3,1-benzoxazin-1(4H)-yl)piperidine |
|---|
| Gene, Accession, CAS # | CAS: 162042-44-6 |
|---|
| Catalog # | 2410/10 |
|---|
| Price | |
|---|
| Order / More Info | L-371,257 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 22651925, 27995495 |
|---|